iSpeak Blog
Does your company only focus on how to get the product to patient without considering what happens if product needs to be retuned?
Greg Hottell
Glaxosmithkline
Director
Greg Hottell is a Director in the Clinical Supply Chain team at GSK, where he is responsible for ensuring cost-effective, patient-focused supply of investigational product for GSK’s pharmaceutical development portfolio. Since joining GSK in 2011, Greg implemented an end-to-end clinical supplies planning platform, helped redesign GSK’s approach to clinical supplies blinding and unblinding risk management, served as an implementation lead for Forecasting and Planning systems, and has implemented Network Capacity Planning for the Clinical Supply Chain.
Greg is a member of the ISPE North American Investigational Product Community of Practice Steering Committee. Additionally, he has been active with the Global Clinical Supplies Group since 2016 facilitating workshops, presenting, and authoring white papers.
Greg has been a Supply Chain professional since 1999, most recently holding positions of increasing responsibility at Eli Lilly & Company and Fisher Clinical Services prior to joining GSK. He holds a bachelor’s degree in Operations Management, an MBA, and is a Certified Fellow in Production and Inventory Management (CPIM-F) through APICS.
Greg is a member of the ISPE North American Investigational Product Community of Practice Steering Committee. Additionally, he has been active with the Global Clinical Supplies Group since 2016 facilitating workshops, presenting, and authoring white papers.
Greg has been a Supply Chain professional since 1999, most recently holding positions of increasing responsibility at Eli Lilly & Company and Fisher Clinical Services prior to joining GSK. He holds a bachelor’s degree in Operations Management, an MBA, and is a Certified Fellow in Production and Inventory Management (CPIM-F) through APICS.
Related Articles